[Clinical studies of PC 904 in pediatrics (author's transl)].

Abstract

PC-904 was administered to 3 pediatric patients with serious infections resistant clinically to other antibiotics (2 cases of sepsis and 1 case of pseudomonal pneumonia). Daily dosage was 100 approximately 150 mg/kg and intravenous infusions were carried out in 2 or 3 divided doses. This drug showed clinically and bacteriologically good response in these patients without any side effect, and was considered to be a useful drug or worthwhile to use in the treatment of the serious infectious diseases such as sepsis or pseudomonal infections.

• Authors: M Kawamura, K Uozumi, T Maki, N Tauchi, Y Takashima
• Journal: The Japanese journal of antibiotics (Jpn J Antibiot) Vol. 31 Issue 7 Pg. 395-400 (Jul 1978) ISSN: 0368-2781 [Print] Japan
• PMID: 691264 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Naphthyridines
• Ampicillin

Topics

• Age Factors
• Ampicillin (administration & dosage, analogs & derivatives, therapeutic use)
• Child
• Female
• Humans
• Infant
• Injections, Intravenous
• Male
• Naphthyridines (administration & dosage, therapeutic use)
• Pneumonia (drug therapy)
• Pseudomonas Infections (drug therapy)
• Sepsis (drug therapy)